These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1151768)

  • 21. [Anti-arrhythmic effects of injectable aprindine in the dog].
    Cheymol G; Gilbert JC; Mouillé P
    Therapie; 1974; 29(5):719-30. PubMed ID: 4549334
    [No Abstract]   [Full Text] [Related]  

  • 22. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide.
    Kis A; Végh A; Papp JG; Parratt JR
    J Mol Cell Cardiol; 1999 Jun; 31(6):1229-41. PubMed ID: 10371697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL; Ambrosioni E; Bracchetti D; Magnani B
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):396-403. PubMed ID: 500254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac effects of aprindine in patients with or without cardiac dysfunction: echocardiographic and clinical evaluation.
    Shimada R; Araki H; Orita Y; Nakagaki O; Nakamura M
    Clin Ther; 1983; 5(4):348-56. PubMed ID: 6871919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK; Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of thioridazine on electrical and ischemic ventricular fibrillation in the dog heart in situ.
    Davis JC; Bigger JT
    J Pharmacol Exp Ther; 1981 Jan; 216(1):39-44. PubMed ID: 7452506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart.
    Pelleg A; Roth A; Shargordsky B; Belhassen B; Chagnac A; Laniado S
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):239-43. PubMed ID: 4033300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological effects of aprindine on A-V conduction in the dog.
    Ferrero Cabedo JA; Insa Pérez LD; López Merino V; Botella Solana S; Brugger Auban A; Esplugues Requena J
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):154-63. PubMed ID: 747461
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of antiarrhythmic agents on ventricular arrhythmias following myocardial infarct induced with glass beads in dogs (author's transl)].
    Kimoto S; Haruna M; Nakao T; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):163-71. PubMed ID: 7327447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic properties of MJ 9067 in acute animal models.
    Byrne JE; Gomoll AW; McKinney GR
    J Pharmacol Exp Ther; 1977 Jan; 200(1):147-54. PubMed ID: 401883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of arrhythmias following ligation of the circumflex artery.
    Armiger LC; Elswijk JG
    J Thorac Cardiovasc Surg; 1975 Jun; 69(6):891-4. PubMed ID: 166259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.
    Yoshimura A; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):420-6. PubMed ID: 10367104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of veratrine on the in situ dog heart: evidence for increased ventricular fibrillation threshold.
    Arbel ER; Glick G
    J Pharmacol Exp Ther; 1979 Feb; 208(2):314-8. PubMed ID: 762666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MD770207 (carocainide) on experimental ventricular arrhythmias.
    Pourrias B; Huerta F; Santamaria R; Tisne Versailles J
    Arch Int Pharmacodyn Ther; 1983 May; 263(1):85-102. PubMed ID: 6615084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and antiarrhythmic effects of aprindine (AC1802) during partial occlusion of a coronary artery in the pig.
    Verdouw PD; Remme WJ; Hugenholtz PG
    Cardiovasc Res; 1977 Jul; 11(4):317-23. PubMed ID: 890709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.